World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   654 records for 232 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02237547
Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
09/09/2014
RecruitingNCT02237846
Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis
09/09/2014
Not recruitingNCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
25/08/2014
Not recruitingNCT02227290
Pediatric Subjects With Tinea Corporis
25/08/2014
RecruitingNCT02192736
Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma
14/07/2014
RecruitingNCT02192749
Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism
12/07/2014
RecruitingNCT02111135
Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life
08/04/2014
RecruitingCTRI/2014/04/004518
To assess long term efficacy, safety, tolerability and usability of Secukinumab in patients with active Rheumatid Artheritis
02-04-2014
RecruitingNCT02091986
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 µg and Symbicort pMDI 80/4.5 µg, Compared With Budesonide pMDI 80 µg
18/03/2014
AuthorisedEUCTR2013-003331-30-AT
A study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-003331-30-FIA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.18/02/2014
AuthorisedEUCTR2013-003331-30-ITA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.18/02/2014
AuthorisedEUCTR2013-003331-30-NLA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.04/03/2014
AuthorisedEUCTR2013-003331-30-DEA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.25/02/2014
AuthorisedEUCTR2013-003331-30-ESA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.07/03/2014
AuthorisedEUCTR2013-003331-30-PTA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.25/02/2014
AuthorisedEUCTR2013-003331-30-PLA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.12/03/2014
AuthorisedEUCTR2013-003331-30-GRA study comparing the clinical benefit and side effects of MPDL3280A to docetaxel in patients with lung cancer who have not benefited from platinum-containing cancer drugs.24/03/2014
17/02/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history